title: Improved Muscular Weakness During Asthma Exacerbation.
authors.affiliation: CRMN Hôpital de la Citadelle, Liège, Belgium.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Delstanche
authors.affiliation: CRMN Hôpital de la Citadelle, Liège, Belgium2Institute I-Motion, Armand Trousseau Hospital, Paris, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Servais
authors.affiliation: Institute I-Motion, Armand Trousseau Hospital, Paris, France.
authors.forename: Teresa
authors.initials: T
authors.lastname: Gidaro
mesh_terms: D000420:Albuterol / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D003937:Diagnosis, Differential; D004576:Electromyography; D006801:Humans; D008141:Lordosis / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009124:Muscle Proteins / Q000235:genetics; D018908:Muscle Weakness / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D009157:Myasthenia Gravis / Q000150:complications* / Q000503:physiopathology / Q000628:therapy
chemical_list: D018927:Anti-Asthmatic Agents; C511692:DOK7 protein, human; D009124:Muscle Proteins; D000420:Albuterol